From: Survival analysis of extramammary Paget’s disease (EMPD) in a tertiary hospital in Taiwan
Variate | Mortality rate | Sub-HR | 95% CI | p-value |
---|---|---|---|---|
Gender | ||||
Female | 16.67% | Reference | Reference | Reference |
Male | 39.53% | 2.737 | 0.632–11.859 | 0.1784 |
Age | ||||
Age less than 75 years old | 24.00% | Reference | Reference | Reference |
Age= 75 years old or more | 43.33% | 2.127 | 0.808–5.600 | 0.1265 |
Lesion site | ||||
Genital region or others | 26.32% | Reference | Reference | Reference |
Perianal or perineal region | 52.94% | 2.338 | 0.948–5.765 | 0.0651 |
Size of lesion | ||||
Lesion = 2 cm or less | 26.32% | Reference | Reference | Reference |
Lesion lager than 2 cm | 38.89% | 1.624 | 0.584–4.514 | 0.3527 |
Invasion of dermis | ||||
No dermal invasion | 28.95% | Reference | Reference | Reference |
Micro-invasion | 20.00% | 0.695 | 0.154–3.137 | 0.6362 |
Deep dermal invasion | 85.71% | 5.167 | 1.876–14.230 | 0.0015 |
Metastasis status | ||||
Without metastasis | 27.08% | Reference | Reference | Reference |
Metastatic diseases | 85.71% | 4.513 | 1.683–12.103 | 0.0028 |
Recurrence (N=51) | ||||
No recurrence | 27.91% | Reference | Reference | Reference |
With recurrence | 62.50% | 2.587 | 0.907–7.382 | 0.0756 |
Concurrent malignancy | ||||
No concurrent malignancy | 29.41% | Reference | Reference | Reference |
Adnexal carcinoma | 33.33% | 1.180 | 0.151–9.225 | 0.8744 |
Internal malignancy | 44.44% | 1.595 | 0.629–4.044 | 0.3249 |
Types of treatment | ||||
With surgical excision | 31.91% | Reference | Reference | Reference |
Without surgical excision | 50.00% | 1.642 | 0.544–4.950 | 0.3787 |
Margin status (N=47) | ||||
Margin not free | 33.33% | Reference | Reference | Reference |
Margin free | 31.03% | 0.911 | 0.324–2.561 | 0.8596 |
Intraepithelial lesion (N= 31) | ||||
Margin not free | 37.50% | Reference | Reference | Reference |
Margin free | 21.74% | 0.528 | 0.126–2.211 | 0.3822 |